Drugs / Omega-3-acids ethyl esters
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT02551172 | Oct 2014 → Jan 2016 | hyperlipidemia | Hanmi Pharmaceutical Company Limited | Unknown | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Omega-3-acids ethyl esters | “Rosuvastatin + Omega-3-acids ethyl esters” NCT02551172 ↗ |